Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

Mintel, the experts in what consumers want and why, has today announced four key trends that will shape the global food and drink industry in the years ahead. In 2025 and beyond, expect to see GLP-1 ...

IN a world with soaring obesity rates, fat jabs have arrived and taken the world of the rich and beautiful by storm. The injections have allegedly helped celebrities like Elon Musk, Sharon ...

The UK government starts a trial offering weight loss drug Mounjaro to unemployed obese individuals to improve health and ...

The Chancellor would riposte that she has changed her mind because the facts have changed: she must now raise £40bn to ...

The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...

The latest plan to tackle obesity in the UK could also help to get people back into work, but what are the risks?

UK Health Minister Wes Streeting recently proposed to provide new weight-loss injections to unemployed individuals to tackle growing obesity rates in the country.

The NHS cannot meet the “tidal wave” of demand for weight-loss jabs, medics say. A report calling for a review of existing treatment services has been backed by more than 200 healthcare professionals, ...

The logic suggested by the Lilly trial is the opposite, however. It proposes that being overweight is a primary cause of ...

The new trial aims to gather evidence of the effects of the drug tirzepatide – sold by pharmaceutical company Lily under brand name Mounjaro ...

Studies show that people with obesity are more likely to find that ill health affects their productivity and attendance at work.